{"url":"https://lda.senate.gov/api/v1/filings/64201b31-e034-4caa-a07c-7c4c874ff5ab/","filing_uuid":"64201b31-e034-4caa-a07c-7c4c874ff5ab","filing_type":"4@","filing_type_display":"4th Quarter - Termination Amendment","filing_year":2013,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/64201b31-e034-4caa-a07c-7c4c874ff5ab/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Janet Lambert, Vice President, Government Relations","dt_posted":"2014-04-23T09:11:17.537000-04:00","termination_date":"2013-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1050 K STREET, NW","registrant_address_2":"SUITE 310","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400391833,"url":"https://lda.senate.gov/api/v1/registrants/400391833/","house_registrant_id":null,"name":"LIFE TECHNOLOGIES CORPORATION","description":"GLOBAL BIOTECHNOLOGY TOOLS COOMPANY","address_1":"1050 K STREET, NW","address_2":"SUITE 310","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN COTTINGHAM","contact_telephone":"+1 760-476-6987","dt_updated":"2022-04-06T16:06:21.614464-04:00"},"client":{"id":190065,"url":"https://lda.senate.gov/api/v1/clients/190065/","client_id":12,"name":"LIFE TECHNOLOGIES CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-01-01"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"H.R. 3309:  The Innovation Act; Provisions regarding patent litigation reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48915,"prefix":"ms","prefix_display":"MS.","first_name":"JANET","nickname":null,"middle_name":"LYNCH","last_name":"LAMBERT","suffix":null,"suffix_display":null},"covered_position":"N/A","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics.\nS. 1871:  The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":52975,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"MUHLBERG","suffix":null,"suffix_display":null},"covered_position":"N/A","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests.\nDraft and final guidance regarding commercially distributed in vitro diagnostic products labeled \"For Research Only\" or \"Investigational Use Only\"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48915,"prefix":"ms","prefix_display":"MS.","first_name":"JANET","nickname":null,"middle_name":"LYNCH","last_name":"LAMBERT","suffix":null,"suffix_display":null},"covered_position":"N/A","new":false},{"lobbyist":{"id":52975,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"MUHLBERG","suffix":null,"suffix_display":null},"covered_position":"N/A","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014;  Provisions regarding National Institutes of Health funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48915,"prefix":"ms","prefix_display":"MS.","first_name":"JANET","nickname":null,"middle_name":"LYNCH","last_name":"LAMBERT","suffix":null,"suffix_display":null},"covered_position":"N/A","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}